Medpace Holdings, Inc. MEDP Return on equity

Return on equity at other companies

Thermo Fisher ScientificTMO

13.5%+0.1pp

Labcorp HoldingsLH

11.7%+2.5pp

IQVIAIQV

23%+3.2pp

Fortrea Holdings Inc.FTRE

-15.3%-7.0pp

Oric Pharmaceuticals, Inc.ORIC

-42.6%-4.6pp

Lifecore Biomedical, Inc.LFCR

-612.1%—

FAQ

What is Medpace Holdings, Inc.'s return on equity?

Medpace Holdings, Inc. (MEDP) reported return on equity of 162.2% in Q2 2026.

How has Medpace Holdings, Inc.'s return on equity changed year-over-year?

Medpace Holdings, Inc.'s return on equity increased by 81.4% year-over-year, from 89.4% to 162.2%.

What is the long-term trend for Medpace Holdings, Inc.'s return on equity?

Over 5 years (2020 to 2025), Medpace Holdings, Inc.'s return on equity has grown at a 29.9% compound annual growth rate (CAGR), from 19% to 70.2%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.